| abstract |
The present invention relates to compositions comprising a mixture comprising or, alternatively, consisting of: the bacterial strain Bifidobacterium bifidum MIMBb23sg or BbflBSCM (DSM 32708), at least one or more bacterial strains selected from group A comprising the strains B. breve BbIBSOI (DSM 33231), B. breve BblBS02 (DSM 33232), B. animalis subsp. lactis BIIBS01 (DSM 33233) and L. plantarum LpIBSOI (DSM 33234) and, optionally, at least one further bacterial strain selected from a bacterial strain L. casei DG® (CNCM 1-1572) and a bacterial strain L. paracasei LPC-S01™ (DSM 26760). Lastly, the present invention relates to said compositions for use in a method for the treatment of gastrointestinal diseases, disorders or symptoms, in particular functional gastrointestinal disorders, such as, for example irritable bowel syndrome (IBS). |